Jinghua Pharmaceutical Group Co., Ltd.

SZSE:002349.SZ

8.74 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 1,490.4471,573.061,357.8681,281.3531,157.3891,354.7061,120.92881.487780.334577.754732.618665.382375.502274.32259.387234.869229.554209.836
Cost of Revenue 797.492837.915725.685662.32631.158703.911561.858443.814479.698354.482521.655470.9230.321133.394133.372128.612129.563127.48
Gross Profit 692.955735.145632.183619.033526.232650.795559.062437.673300.636223.271210.963194.482145.181140.926126.014106.25799.99182.356
Gross Profit Ratio 0.4650.4670.4660.4830.4550.480.4990.4970.3850.3860.2880.2920.3870.5140.4860.4520.4360.392
Reseach & Development Expenses 64.6286.9874.75852.05382.75540.31937.66742.94126.63915.71311.86810.5611.12700000
General & Administrative Expenses 118.80540.31937.79243.49333.22933.41335.79223.59522.26918.29620.39914.3488.14637.14532.73330.50330.58729.466
Selling & Marketing Expenses 227.973252.118215.02177.084174.943169.038140.888116.085104.79489.5279.32472.63657.47950.9149.78136.97530.05727.06
SG&A 332.193292.437252.812220.577208.172202.451176.68139.68127.063107.81699.72386.98365.62588.05582.51467.47860.64456.526
Other Expenses -14.394120.266112.98794.464100.302-5.00545.9248.4973.95611.29512.81728.31518.7051.353-0.4510.2656.139-0.461
Operating Expenses 397.018499.682440.556367.093391.229332.1285.237261.571212.278175.598160.298146.62104.92990.93185.62969.88163.12158.696
Operating Income 330.854251.484180.505269.228145.876293.472170.897193.68992.98939.84239.24743.89338.4948.92739.52731.60233.06617.982
Operating Income Ratio 0.2220.160.1330.210.1260.2170.1520.220.1190.0690.0540.0660.1030.1780.1520.1350.1440.086
Total Other Income Expenses Net -1.159-1.271-1.6180.465-2.501-5.00545.9248.2973.73511.2483.57728.20418.6871.257-0.451-4.5095.794-0.709
Income Before Tax 329.695250.213178.88763.745-500.66288.467216.821201.98596.72451.0942.82472.09757.17650.18439.07631.86738.8617.274
Income Before Tax Ratio 0.2210.1590.1320.05-0.4330.2130.1930.2290.1240.0880.0580.1080.1520.1830.1510.1360.1690.082
Income Tax Expense 53.22937.91738.92835.8223.68928.39726.49528.52614.88210.4632.15112.488.8257.5446.2765.70313.2665.472
Net Income 247.697212.225160.70227.925-524.349229.665175.32165.0378.08139.46835.59749.22348.10242.63932.826.16325.59311.802
Net Income Ratio 0.1660.1350.1180.022-0.4530.170.1560.1870.10.0680.0490.0740.1280.1550.1260.1110.1110.056
EPS 0.30.260.20.034-0.640.280.210.20.10.0660.0590.0820.080.0730.0730.0580.0570.027
EPS Diluted 0.30.260.20.034-0.640.280.210.20.10.0660.0590.0820.080.0730.0730.0580.0570.027
EBITDA 417.611370.042294.939162.26-400.796373.48285.619260.876142.18595.12771.08791.52166.53659.25649.88944.95952.92338.887
EBITDA Ratio 0.2750.2480.2240.2760.1960.2990.3460.30.2030.1780.1190.1460.1890.2190.1910.1970.2320.191